Arrowgrass Capital Partners (US)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-11,684
| Closed | -$4.39M | – | 248 |
|
|
2017
Q4 | $4.39M | Buy |
11,684
+5,812
| +99% | +$2.19M | 0.04% | 126 |
|
|
2017
Q3 | $2.63M | Buy |
5,872
+811
| +16% | +$363K | 0.02% | 194 |
|
|
2017
Q2 | $2.49M | Sell |
5,061
-8,793
| -63% | -$4.32M | 0.02% | 219 |
|
|
2017
Q1 | $5.37M | Buy |
13,854
+7,117
| +106% | +$2.76M | 0.06% | 152 |
|
|
2016
Q4 | $2.47M | Buy |
6,737
+4,131
| +159% | +$1.52M | 0.03% | 138 |
|
|
2016
Q3 | $1.05M | Sell |
2,606
-250
| -9% | -$101K | 0.01% | 168 |
|
|
2016
Q2 | $997K | Sell |
2,856
-1,782
| -38% | -$622K | 0.01% | 163 |
|
|
2016
Q1 | $1.67M | Buy |
+4,638
| New | +$1.67M | 0.02% | 144 |
|
|
2015
Q4 | – | Sell |
-264
| Closed | -$123K | – | 239 |
|
|
2015
Q3 | $123K | Buy |
+264
| New | +$123K | ﹤0.01% | 207 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 315 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 297 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 270 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 236 |
|